CCM

Catalio Capital Management Portfolio holdings

AUM $479M
1-Year Est. Return 140.7%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+140.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
-$87.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$31.3M
2
+$18.2M
3
+$17.6M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$15.5M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$14.2M

Top Sells

1
+$31.4M
2
+$27.9M
3
+$25M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$23M
5
GILD icon
Gilead Sciences
GILD
+$17.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
1
Dianthus Therapeutics
DNTH
$4.6B
$47M 9.82%
560,308
-93,264
BBIO icon
2
BridgeBio Pharma
BBIO
$13.2B
$32.1M 6.7%
+432,014
ASND icon
3
Ascendis Pharma A/S
ASND
$13.5B
$29.5M 6.17%
129,111
+9,846
BMY icon
4
Bristol-Myers Squibb
BMY
$116B
$25.5M 5.33%
420,727
-227,172
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.6B
$24.4M 5.09%
1,043,670
-153,137
GILD icon
6
Gilead Sciences
GILD
$160B
$22.8M 4.77%
163,905
-125,407
TERN
7
DELISTED
Terns Pharmaceuticals
TERN
$21.6M 4.5%
409,031
+272,073
DFTX
8
Definium Therapeutics
DFTX
$2.68B
$19.6M 4.1%
+1,037,984
SLNO
9
DELISTED
Soleno Therapeutics
SLNO
$19.3M 4.04%
577,808
+217,468
BSX icon
10
Boston Scientific
BSX
$72.6B
$18.8M 3.92%
299,318
-61,110
RARE icon
11
Ultragenyx Pharmaceutical
RARE
$2.3B
$17.8M 3.72%
850,797
+688,247
INCY icon
12
Incyte
INCY
$20.2B
$17.1M 3.58%
+182,101
CYTK icon
13
Cytokinetics
CYTK
$9.81B
$14.2M 2.97%
215,501
-42,880
NTRA icon
14
Natera
NTRA
$31.8B
$14.2M 2.96%
70,907
+8,634
CRVS icon
15
Corvus Pharmaceuticals
CRVS
$986M
$13M 2.73%
+891,933
GPCR icon
16
Structure Therapeutics
GPCR
$2.78B
$12.3M 2.57%
255,379
+2,478
MLYS icon
17
Mineralys Therapeutics
MLYS
$2.07B
$11.9M 2.48%
439,041
+107,192
EW icon
18
Edwards Lifesciences
EW
$50.4B
$11.6M 2.42%
144,607
-42,441
MANE
19
Veradermics Inc
MANE
$4.23B
$11M 2.29%
+173,582
ADPT icon
20
Adaptive Biotechnologies
ADPT
$2.89B
$10M 2.1%
722,784
-98,411
HTFL
21
Heartflow Inc
HTFL
$2.48B
$9.82M 2.05%
403,588
+289,731
KALV icon
22
KalVista Pharmaceuticals
KALV
$1.43B
$8.59M 1.79%
+426,551
QURE icon
23
uniQure
QURE
$1.77B
$8.03M 1.68%
491,116
+202,771
IRON icon
24
Disc Medicine
IRON
$2.72B
$7.86M 1.64%
122,978
+12,551
SEPN
25
Septerna Inc
SEPN
$1.41B
$7.07M 1.48%
294,360
1
2 3